Genmab A/S (GMAB)
NASDAQ: GMAB · IEX Real-Time Price · USD
27.75
+0.51 (1.87%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Genmab Market Cap
Genmab has a market cap or net worth of $18.08 billion as of July 22, 2024. Its market cap has decreased by -28.36% in one year.
Market Cap
18.08B
Enterprise Value
13.91B
1-Year Change
-28.36%
Ranking
Category
Stock Price
$27.75
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $18.08B, an increase of 4,199.79%. That is a compound annual growth rate of 35.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 18.35B | -12.77% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNTech SE | 20.32B |
| Teva Pharmaceutical | 19.04B |
| Align Technology | 18.94B |
| Illumina | 18.24B |
| Hologic | 18.23B |
| The Cooper Companies | 18.07B |
| Baxter International | 18.01B |
| Waters | 17.96B |